GO:1901704 L-glutamine biosynthetic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901704 (L-glutamine biosynthetic process) describes the chemical reactions and pathways that result in the formation of L-glutamine, a conditionally essential amino acid and central nitrogen carrier.
• L-glutamine is synthesized from glutamate and ammonia by glutamine synthetase (GLUL) and is also produced industrially by bacterial fermentation for clinical and nutritional use.
• Beyond protein synthesis, L-glutamine feeds nucleotide biosynthesis, glutathione production, and anaplerosis, making its biosynthetic pathway a key node in cancer metabolism and redox homeostasis.
• Clinically, L-glutamine supplementation is used in sickle cell disease to reduce vaso-occlusive crises and in oncology to protect against mucositis and neurotoxicity.
• Tumour cells, including glioblastoma stem cells, reprogram glutamine oxidation and glycolysis, highlighting the pathway as a therapeutic target.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of GLUL and related genes in glutamine biosynthesis.
Description
L-glutamine is the most abundant free amino acid in human plasma and serves as a primary nitrogen donor for nucleotide and amino sugar synthesis. The Gene Ontology term GO:1901704, L-glutamine biosynthetic process, captures the enzymatic steps that build L-glutamine from precursor molecules, principally glutamate and ammonia. This process is essential for nitrogen balance, acid-base homeostasis, and the supply of carbon and nitrogen for biosynthetic reactions. In cancer, glutamine biosynthesis and utilization support rapid proliferation, and targeting this pathway is an active therapeutic strategy. In sickle cell disease, L-glutamine supplementation reduces oxidative stress and improves clinical outcomes, underscoring the pathway's translational relevance. Understanding the genes, regulation, and disease links of L-glutamine biosynthesis is therefore critical for researchers in metabolism, oncology, and hematology.
L-glutamine biosynthetic process At A Glance
| GO ID | GO:1901704 |
|---|---|
| GO term | L-glutamine biosynthetic process |
| Ontology | biological_process |
| Synonym | L-glutamine anabolism; L-glutamine biosynthesis; L-glutamine formation; L-glutamine synthesis |
| Major function | Synthesis of L-glutamine from glutamate and ammonia, supporting nitrogen transport, nucleotide synthesis, and redox balance |
| Key enzyme | Glutamine synthetase (GLUL) |
| Pathway context | Glutamate metabolism; nitrogen assimilation; anaplerosis |
| Disease relevance | Cancer, sickle cell disease, neuroprotection, enterocyte protection |
What Is GO:1901704?
GO:1901704 (L-glutamine biosynthetic process) is defined as the chemical reactions and pathways resulting in the formation of L-glutamine. It encompasses the enzymatic conversion of precursors such as L-glutamate and ammonia into L-glutamine, primarily through the action of glutamine synthetase (GLUL). This term is a biological process in the Gene Ontology and is synonymous with L-glutamine anabolism, L-glutamine biosynthesis, L-glutamine formation, and L-glutamine synthesis.
Why Is L-glutamine biosynthetic process Important in Cell Biology?
L-glutamine biosynthesis is a central metabolic hub because L-glutamine is the most abundant free amino acid and a major nitrogen carrier. It supplies nitrogen for nucleotide and amino sugar synthesis, fuels the TCA cycle through anaplerosis, and is a precursor for glutathione, the major cellular antioxidant. Consequently, dysregulation of this pathway contributes to cancer progression, oxidative stress, and impaired intestinal and neurological function. Understanding GO:1901704 is therefore essential for developing metabolic therapies and for interpreting experimental models of glutamine dependence.
• L-glutamine is the most abundant free amino acid in plasma and a primary nitrogen donor.
• Glutamine synthetase (GLUL) catalyzes the ATP-dependent condensation of glutamate and ammonia to form L-glutamine.
• The pathway supports nucleotide biosynthesis, amino sugar synthesis, and glutathione production.
• Cancer cells frequently reprogram glutamine metabolism to sustain proliferation, making it a therapeutic target.
• L-glutamine supplementation reduces oxidative stress and clinical complications in sickle cell disease.
• Glutamine protects enterocytes from apoptosis by regulating glutathione-related redox homeostasis.
• In endurance exercise, L-glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression.
• Glial remodeling and neuroprotective effects of L-glutamine are observed in enteric nervous system models.
• Industrial production of L-glutamine relies on bacterial fermentation, highlighting its biotechnological importance.
• Glioblastoma stem cell energetics depend on regulation of glycolysis and glutamine oxidation.
What Happens During L-glutamine biosynthetic process?
Substrate acquisition and ammonia assimilation
In simple terms: The cell gathers glutamate and ammonia, the raw materials for making glutamine.
L-glutamine biosynthesis begins with the availability of L-glutamate and ammonia. Glutamate can be derived from transamination reactions or from the TCA cycle intermediate alpha-ketoglutarate. Ammonia is generated from amino acid catabolism or directly assimilated. In cancer cells, glutamine oxidation and glycolysis are coordinately regulated to supply these substrates.
Enzymatic condensation by glutamine synthetase
In simple terms: An enzyme called glutamine synthetase joins glutamate and ammonia together to form glutamine.
The central step is catalyzed by glutamine synthetase (GLUL), which uses ATP to condense L-glutamate and ammonia into L-glutamine, releasing ADP and inorganic phosphate. This enzyme is highly conserved and is the primary route for de novo L-glutamine synthesis in mammals.
Regulation by substrate availability and feedback
In simple terms: The pathway speeds up or slows down depending on how much glutamine the cell already has.
Glutamine synthetase activity is regulated by substrate availability, allosteric feedback from glutamine, and hormonal signals. In cancer, oncogenic signaling such as FAK modulates glutamine oxidation and glycolysis, indirectly influencing glutamine biosynthesis and utilization. Redox status also impacts the pathway, as glutathione synthesis consumes glutamine-derived glutamate.
Integration with nitrogen and redox metabolism
In simple terms: Glutamine made in this pathway is used to build other molecules and to protect cells from stress.
Newly synthesized L-glutamine serves as a nitrogen donor for nucleotide and amino sugar synthesis, and as a precursor for glutathione, the major antioxidant. In enterocytes, L-glutamine attenuates apoptosis by regulating glutathione-related redox homeostasis. In endurance exercise, L-glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression.
Physiological and clinical roles
In simple terms: Glutamine made by this pathway helps the body handle stress, disease, and normal metabolism.
L-glutamine biosynthesis supports intestinal health, immune function, and acid-base balance. In sickle cell disease, L-glutamine supplementation reduces oxidative stress and clinical complications. In tumor-bearing rats, L-glutamine supplementation promotes glial remodeling and neuroprotection in the enteric nervous system. These roles underscore the pathway's broad physiological importance.
Key Genes Involved in GO:1901704 L-glutamine biosynthetic process
The following genes and proteins are experimentally implicated in L-glutamine biosynthesis, its regulation, and its downstream metabolic roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLUL | Encodes glutamine synthetase, the enzyme that catalyzes L-glutamine synthesis from glutamate and ammonia | Core enzyme of GO:1901704; target for metabolic studies and cancer therapy |
| GLS | Encodes glutaminase, which converts glutamine to glutamate; opposes glutamine synthesis | Regulates glutamine flux and is a therapeutic target in cancer |
| GOT1 | Glutamic-oxaloacetic transaminase 1, generates glutamate for glutamine synthesis | Links amino acid metabolism to glutamine biosynthesis |
| GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial glutamate production | Supports anaplerosis and glutamine synthesis |
| GLUD1 | Glutamate dehydrogenase 1, produces glutamate from alpha-ketoglutarate and ammonia | Provides substrate for GLUL |
| GLUD2 | Glutamate dehydrogenase 2, mitochondrial glutamate metabolism | Contributes to glutamine precursor supply |
| ASNS | Asparagine synthetase, uses glutamine as nitrogen donor | Downstream consumer of glutamine; links to amino acid stress |
| CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; uses glutamine for pyrimidine synthesis | Glutamine-dependent nucleotide synthesis |
| GFPT1 | Glutamine-fructose-6-phosphate transaminase 1; uses glutamine for hexosamine synthesis | Glutamine-dependent glycosylation |
| GCLC | Glutamate-cysteine ligase catalytic subunit; consumes glutamate for glutathione synthesis | Links glutamine metabolism to redox homeostasis |
| GCLM | Glutamate-cysteine ligase modifier subunit; regulates glutathione synthesis | Modulates glutamine-glutathione axis |
| GSS | Glutathione synthetase; completes glutathione synthesis from glutamine-derived glutamate | Redox protection |
| HSPA1A | Heat shock protein family A member 1A; induced by heat shock factor-1 | Linked to glutamine supplementation in exercise |
| HSF1 | Heat shock factor 1; transcription factor regulating stress response | Upregulated by L-glutamine supplementation |
| SLC1A5 | Glutamine transporter; imports glutamine | Regulates intracellular glutamine levels |
| SLC7A5 | L-type amino acid transporter; exchanges glutamine for essential amino acids | Links glutamine to mTOR signaling |
| FAK | Focal adhesion kinase; modulates glycolysis and glutamine oxidation | Regulates glioblastoma stem cell energetics |
| MYC | Oncogene; promotes glutamine metabolism and biosynthesis | Drives glutamine addiction in cancer |
How Is L-glutamine biosynthetic process Regulated?
L-glutamine biosynthesis is regulated at multiple levels. Substrate availability of glutamate and ammonia directly controls flux through glutamine synthetase (GLUL). Allosteric feedback by glutamine and feedback inhibition by AMP and other nucleotides modulate enzyme activity. Hormonal signals, including glucocorticoids and insulin, influence GLUL expression in a tissue-specific manner. In cancer, oncogenic signaling pathways such as MYC and FAK reprogram glutamine metabolism, affecting both synthesis and utilization. Redox status also plays a role, as glutathione synthesis consumes glutamine-derived glutamate, creating a demand-driven regulation. Additionally, heat shock factor-1 (HSF1) is induced by L-glutamine supplementation, linking stress response to glutamine metabolism.
L-glutamine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLUL | Cancer metabolism; glutamine dependence | GLUL knockout cancer cell lines; xenograft models |
| FAK | Glioblastoma stem cell energetics | FAK knockout or point-mutant glioblastoma stem cells |
| GCLC | Oxidative stress; sickle cell disease | GCLC knockout erythroid cells; glutamine supplementation |
| GSS | Redox imbalance; enterocyte apoptosis | GSS knockout intestinal epithelial cells |
| HSF1 | Stress response; exercise adaptation | HSF1 knockout or overexpression in liver cells |
Cancer metabolism and glutamine addiction
Many cancer cells exhibit increased glutamine consumption and dependence, a phenomenon known as glutamine addiction. Targeting glutamine metabolism, including biosynthesis and oxidation, is a therapeutic strategy for cancer. In glioblastoma stem cells, FAK modulates glycolysis and glutamine oxidation, supporting stem cell energetics and tumor growth. Therefore, enzymes of L-glutamine biosynthesis such as GLUL are candidate targets for metabolic therapy.
Sickle cell disease and oxidative stress
L-glutamine supplementation reduces oxidative stress and improves clinical outcomes in sickle cell disease, more than just by reducing redox imbalance. The pathway's role in glutathione synthesis provides a mechanistic link: glutamine-derived glutamate is a substrate for glutathione, the major antioxidant. This makes L-glutamine biosynthesis relevant to hematological disorders characterized by oxidative stress.
Enteric nervous system and neuroprotection
In Walker-256 tumor-bearing rats, L-glutamine supplementation promotes glial remodeling and neuroprotective effects on the enteric nervous system. This suggests that L-glutamine biosynthesis and supplementation can influence neural plasticity and protect against tumor-induced neurotoxicity. The pathway may also be relevant in neurodegenerative conditions where glutamine homeostasis is perturbed.
Intestinal health and apoptosis
L-glutamine attenuates apoptosis in porcine enterocytes by regulating glutathione-related redox homeostasis. This indicates that L-glutamine biosynthesis supports intestinal epithelial survival under stress. In endurance-exercise trained rats, L-glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression, further linking the pathway to stress adaptation.
From L-glutamine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is GLUL essential for cancer cell proliferation? | GLUL knockout in cancer cell lines (e.g., glioblastoma, breast) |
| Does a point mutation in GLUL alter catalytic activity? | Point-mutation knock-in of GLUL in isogenic cell lines |
| Can glutamine biosynthesis be visualized in live cells? | Knock-in of fluorescent tag (e.g., GFP) into GLUL locus |
| Does overexpression of GLUL drive glutamine addiction? | GLUL overexpression in non-transformed cells |
| What is the role of FAK in glutamine oxidation? | FAK knockout or point-mutant glioblastoma stem cells |
| Does L-glutamine supplementation protect enteric neurons? | In vivo rat model of Walker-256 tumor with glutamine supplementation |
How to Study the L-glutamine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C/15N isotope tracing | Flux through glutamine biosynthesis and downstream pathways | Cancer metabolism studies |
| Glutamine synthetase activity assay | Enzymatic conversion of glutamate to glutamine | Enzyme kinetics and inhibitor testing |
| CRISPR knockout screens | Genes essential for glutamine biosynthesis or utilization | Identifying metabolic vulnerabilities |
| RNA-seq | Transcript levels of GLUL and related genes | Regulatory studies and disease models |
| Proteomics | Protein abundance and post-translational modifications | Pathway mapping and biomarker discovery |
| Immunofluorescence | Subcellular localization of GLUL and pathway enzymes | Tissue and cell imaging |
| Metabolomics | Intracellular glutamine and related metabolite levels | Pharmacological and genetic perturbations |
| Glutathione assays | Redox status and glutathione levels | Oxidative stress studies |
Metabolic flux analysis
Stable isotope tracing with 13C/15N-labeled glutamine or glutamate allows quantification of flux through L-glutamine biosynthesis and its downstream pathways. This method measures the conversion of glutamate to glutamine and the incorporation of nitrogen into nucleotides and glutathione.
Enzyme activity assays
Glutamine synthetase activity can be measured spectrophotometrically by coupling the reaction to glutamate dehydrogenase or by using the gamma-glutamyl transferase assay. These assays quantify the catalytic capacity of GLUL in cell lysates or purified preparations.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate L-glutamine biosynthesis and glutamine dependence. Such screens have revealed metabolic vulnerabilities in cancer cells and can pinpoint synthetic lethal interactions.
Transcriptomic and proteomic profiling
RNA-seq and mass spectrometry-based proteomics measure expression of GLUL and related genes under different conditions, such as glutamine deprivation or supplementation. These approaches reveal regulatory networks and compensatory mechanisms.
How CRISPR Can Be Used to Study GO:1901704 L-glutamine biosynthetic process
Knockout
CRISPR knockout of GLUL or related genes (e.g., GLS, GCLC) can abolish L-glutamine biosynthesis or its downstream use, revealing essentiality in cancer cell lines and normal cells. Such models help determine whether a gene is required for proliferation under glutamine-limited conditions.
Point Mutation
Introducing point mutations into GLUL (e.g., catalytic residues) via CRISPR base editing or homology-directed repair allows structure-function analysis of the enzyme. This approach can separate catalytic activity from non-enzymatic functions and test drug resistance mutations.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) into the endogenous GLUL locus enables live-cell imaging, protein interaction studies, and quantitative expression analysis without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of GLUL can model glutamine addiction and test whether increased glutamine synthesis drives proliferation or redox protection. Overexpression models are useful for studying gain-of-function phenotypes in cancer and metabolic disorders.
How EDITGENE Supports L-glutamine biosynthetic process Research
Researchers studying L-glutamine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activity. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes such as GLUL, GLS, and FAK in the context of glutamine metabolism.
Contact EDITGENE today to design your custom CRISPR model for L-glutamine biosynthetic process research.
Frequently Asked Questions About L-glutamine biosynthetic process
What is GO:1901704 L-glutamine biosynthetic process?
GO:1901704 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the formation of L-glutamine, primarily from glutamate and ammonia.
What genes are involved in L-glutamine biosynthesis?
Key genes include GLUL (glutamine synthetase), GLS (glutaminase), GLUD1, GOT1, and GOT2, which supply substrates or catalyze the central reaction.
What is the main enzyme for L-glutamine synthesis?
Glutamine synthetase, encoded by GLUL, catalyzes the ATP-dependent condensation of glutamate and ammonia to form L-glutamine.
Why is L-glutamine biosynthesis important in cancer?
Many cancer cells depend on glutamine for proliferation and survival; targeting glutamine metabolism, including biosynthesis, is a therapeutic strategy.
How is L-glutamine used in sickle cell disease?
L-glutamine supplementation reduces oxidative stress and clinical complications in sickle cell disease, partly by supporting glutathione synthesis.
Can CRISPR be used to study L-glutamine biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes like GLUL in glutamine metabolism.
What is the role of glutamine in redox homeostasis?
Glutamine-derived glutamate is a precursor for glutathione, the major cellular antioxidant, linking glutamine biosynthesis to redox balance.
How does L-glutamine affect the enteric nervous system?
In tumor-bearing rats, L-glutamine supplementation promotes glial remodeling and neuroprotective effects in the enteric nervous system.
What methods are used to measure L-glutamine biosynthesis?
Isotope tracing, enzyme activity assays, metabolomics, and CRISPR screens are commonly used to measure and perturb the pathway.
Is L-glutamine produced industrially?
Yes, L-glutamine is produced industrially by bacterial fermentation for use in clinical nutrition and cell culture.
Conclusion
GO:1901704 L-glutamine biosynthetic process is a fundamental metabolic pathway with far-reaching implications for cancer, hematology, and neurobiology. The central enzyme GLUL and its regulatory network provide numerous targets for therapeutic intervention and experimental investigation. By leveraging CRISPR-based models and advanced screening technologies, researchers can dissect the causal roles of specific genes in this pathway. EDITGENE's services support these efforts with precise, validated cell models and bioinformatics solutions.
References
- 1. Jin J et al.. 2023. Targeting glutamine metabolism as a therapeutic strategy for cancer.. Exp Mol Med 55(4):706-715 PMID: 37009798
- 2. Labow BI et al.. 2000. Glutamine.. World J Surg 24(12):1503-13 PMID: 11193715
- 3. Kusumoto I. 2001. Industrial production of L-glutamine.. J Nutr 131(9 Suppl):2552S-5S PMID: 11533312
- 4. Jafri F et al.. 2022. L-glutamine for sickle cell disease: more than reducing redox.. Ann Hematol 101(8):1645-1654 PMID: 35568758
- 5. de Souza SRG et al.. 2026. Glial remodeling and neuroprotective effects of L-glutamine supplementation on the enteric nervous system in walker-256 tumor-bearing rats.. Tissue Cell 102:103652 PMID: 42217296
- 6. Masalmeh RHA et al.. 2025. FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation.. Dis Model Mech 18(11) PMID: 40977288
- 7. Petry ÉR et al.. 2015. L-glutamine supplementations enhance liver glutamine-glutathione axis and heat shock factor-1 expression in endurance-exercise trained rats.. Int J Sport Nutr Exerc Metab 25(2):188-97 PMID: 25202991
- 8. Liu N et al.. 2018. l-Glutamine Attenuates Apoptosis in Porcine Enterocytes by Regulating Glutathione-Related Redox Homeostasis.. J Nutr 148(4):526-534 PMID: 29659951
